Gilead Sciences, Inc.
GILD
$96.84
-$1.32-1.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.32B | 1.78B | 1.25B | 1.61B | -4.17B |
| Total Depreciation and Amortization | 696.00M | 693.00M | 690.00M | 694.00M | 690.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 779.00M | 16.00M | 1.72B | 563.00M | 6.16B |
| Change in Net Operating Assets | -1.03B | 483.00M | 642.00M | -1.55B | -459.00M |
| Cash from Operations | 1.76B | 2.98B | 4.31B | 1.33B | 2.22B |
| Capital Expenditure | -104.00M | -147.00M | -141.00M | -130.00M | -105.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -273.00M | -75.00M | -570.00M | -152.00M | -4.04B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.00M | -3.00M | 1.00M | -25.00M | 1.94B |
| Cash from Investing | -415.00M | -225.00M | -710.00M | -307.00M | -2.21B |
| Total Debt Issued | -- | 3.46B | -- | -- | -- |
| Total Debt Repaid | -1.76B | -7.00M | -112.00M | -1.85B | -- |
| Issuance of Common Stock | 252.00M | 173.00M | 98.00M | 5.00M | 146.00M |
| Repurchase of Common Stock | -730.00M | -350.00M | -300.00M | -100.00M | -400.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.01B | -973.00M | -983.00M | -972.00M | -990.00M |
| Other Financing Activities | -176.00M | -47.00M | -82.00M | -35.00M | -117.00M |
| Cash from Financing | -3.43B | 2.26B | -1.38B | -2.95B | -1.36B |
| Foreign Exchange rate Adjustments | 19.00M | -55.00M | 44.00M | -11.00M | -18.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.07B | 4.96B | 2.26B | -1.95B | -1.37B |